WallStreetZenWallStreetZen

NASDAQ: KYMR
Kymera Therapeutics Inc Stock Ownership - Who owns Kymera Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kymera Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Bruce N. JacobsChief Financial Officer2025-03-3125,000$2.08
$52.00kBuy
Jeremy G. ChadwickChief Operating Officer2025-03-03252$31.01
$7.81kSell
Ellen ChiniaraChief Legal Officer2025-03-03408$31.01
$12.65kSell
Ellen ChiniaraChief Legal Officer2025-03-031,833$30.33
$55.59kSell
Jeremy G. ChadwickChief Operating Officer2025-03-031,131$30.33
$34.30kSell
Bruce N. JacobsChief Financial Officer2025-03-031,281$31.01
$39.72kSell
Bruce N. JacobsChief Financial Officer2025-03-035,754$30.33
$174.50kSell
Jared GollobChief Medical Officer2025-03-031,045$31.01
$32.40kSell
Jared GollobChief Medical Officer2025-03-034,695$30.33
$142.39kSell
Nello MainolfiChief Executive Officer2025-01-1010,000$2.08
$20.80kBuy

1 of 5

KYMR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KYMR insiders and whales buy or sell their stock.

KYMR Shareholders

What type of owners hold Kymera Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Price T Rowe Associates Inc10.58%6,870,333$178.42MInstitution
Baker Bros Advisors LP9.23%5,995,929$155.71MInstitution
Atlas Venture Associates X LP8.87%5,763,012$149.67MInsider
Atlas Venture Fund X LP8.48%5,504,905$142.96MInsider
Wellington Management Group LLP8.17%5,307,326$137.83MInstitution
Bvf Inc7.95%5,161,801$134.05MInstitution
Avoro Capital Advisors LLC7.93%5,150,000$133.75MInstitution
Atlas Venture Life Science Advisors LLC7.54%4,896,462$127.16MInstitution
Vanguard Group Inc7.53%4,887,312$126.92MInstitution
Fmr LLC7.44%4,830,423$125.45MInstitution

1 of 3

KYMR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KYMR78.79%21.21%Net SellingNet Buying
NAMS70.81%29.19%Net SellingNet Buying
BLTE0.89%0.00%
JANX62.97%37.03%Net SellingNet Buying
TARS71.06%28.94%Net SellingNet Selling
View Top Biotech Stocks

Kymera Therapeutics Stock Ownership FAQ

Who owns Kymera Therapeutics?

Kymera Therapeutics (NASDAQ: KYMR) is owned by 109.74% institutional shareholders, 29.55% Kymera Therapeutics insiders, and 0.00% retail investors. Atlas Venture Associates X LP is the largest individual Kymera Therapeutics shareholder, owning 5.76M shares representing 8.87% of the company. Atlas Venture Associates X LP's Kymera Therapeutics shares are currently valued at $156.52M.

If you're new to stock investing, here's how to buy Kymera Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.